Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Buy
88
RBOT Quote, Financials, Valuation and Earnings
Last price:
$14.53
Seasonality move
:
-15.83%
Day range:
$14.04 - $17.09
52-week range:
$4.27 - $21.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.49x
Volume:
84K
Avg. volume:
49.1K
1-year change:
21.2%
Market cap:
$86.3M
Revenue:
--
EPS (TTM):
-$10.42
Analysts' Opinion
-
Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $11.75, Vicarious Surgical has an estimated downside of -19.58% from its current price of $14.61.
-
Price Target UpsideAccording to analysts, the highest upside price target is $13.00 representing -100% upside increase from its current price of $14.61.
Fair Value
-
According to the consensus of 3 analysts, Vicarious Surgical has -19.58% downside to fair value with a price target of $11.75 per share.
RBOT vs. S&P 500
-
Over the past 5 trading days, Vicarious Surgical has overperformed the S&P 500 by 20.82% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Vicarious Surgical does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Vicarious Surgical has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Vicarious Surgical reported revenues of --.
Earnings Growth
-
Vicarious Surgical has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Vicarious Surgical reported earnings per share of -$2.90.
Enterprise value:
25.5M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$77.3M | -$85.7M | -$67.1M | -$21.4M | -$17.8M | |
| EBITDA | $39.1M | -$67.3M | -$60.3M | -$15.3M | -$16.6M | |
| Diluted EPS | $12.00 | -$15.66 | -$10.42 | -$3.04 | -$2.90 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $191.2M | $131.3M | $113.4M | $64M | |
| Total Assets | -- | $193.4M | $150.7M | $132.1M | $80.6M | |
| Current Liabilities | -- | $3.1M | $11.7M | $7.8M | $8.6M | |
| Total Liabilities | -- | $183.7M | $41.7M | $24.2M | $22.7M | |
| Total Equity | -- | $9.6M | $109M | $107.9M | $57.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$52.6M | -$69.3M | -$49.5M | -$17.3M | -$12.7M | |
| Cash From Investing | -$5.2M | -$51.8M | -$2.5M | -$644K | -$492K | |
| Cash From Financing | -$153K | $53.5M | $36K | $44.2M | -- | |
| Free Cash Flow | -$57.8M | -$71M | -$50.6M | -$17.4M | -$12.7M | |
RBOT
Sector
Market Cap
$86.3M
$49.2M
Price % of 52-Week High
68.19%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
21.21%
-30.94%
Beta (5-Year)
--
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$13.13
200-day SMA
Buy
Level
$8.73
Bollinger Bands (100)
Buy
Level
5.56 - 12.26
Chaikin Money Flow
Sell
Level
-19.5M
20-day SMA
Buy
Level
$13.81
Relative Strength Index (RSI14)
Buy
Level
59.37
ADX Line
Buy
Level
34.54
Williams %R
Neutral
Level
-44.4444
50-day SMA
Buy
Level
$11.57
MACD (12, 26)
Buy
Level
0.41
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Sell
Level
-33.4M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
Stock Forecast FAQ
In the current month, RBOT has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The RBOT average analyst price target in the past 3 months is $11.75.
-
Where Will Vicarious Surgical Stock Be In 1 Year?
According to analysts, the consensus estimate is that Vicarious Surgical share price will drop to $11.75 per share over the next 12 months.
-
What Do Analysts Say About Vicarious Surgical?
Analysts are divided on their view about Vicarious Surgical share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vicarious Surgical is a Sell and believe this share price will rise from its current level to $10.50.
-
What Is Vicarious Surgical's Price Target?
The price target for Vicarious Surgical over the next 1-year time period is forecast to be $11.75 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is RBOT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Vicarious Surgical is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RBOT?
You can purchase shares of Vicarious Surgical via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vicarious Surgical shares.
-
What Is The Vicarious Surgical Share Price Today?
Vicarious Surgical was last trading at $14.53 per share. This represents the most recent stock quote for Vicarious Surgical. Yesterday, Vicarious Surgical closed at $14.61 per share.
-
How To Buy Vicarious Surgical Stock Online?
In order to purchase Vicarious Surgical stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
